On 7/2/19, CEL-SCI Stated they are still waiting on the 298th event to occur!!!!


Upcoming Dates and Milestones

  • June 30   End of their 3rd Quarter.  
  • July 1   Tutes can start filing their 13Fs. In addition to the 3M addition this quarter from the Russell Indexing, expect at least another 1M.  Tute ownership will go from 9% to over 20%!
  • July 2   HC Wainrights First Right of Refusal ends
  • July 2 CEL-SCI updates Corporate Presentation and states: "We are currently waiting for 298 events (deaths) in the two main groups to prove an overall survival benefit. " 
  • Mid July  2 GUESSES: 1) A Shareholder Letter with update on 298  2) Real Analyst coverage
  • August 10ish   Filing of 3rd Quarter 10Q.  Info on cash, warrants and an update on 298
  • Aug 15   Last day for Tutes to file their 13Fs


We Message Board Posters Welcome You!

image7

About CEL-SCI and their Phase III drug candidate Multikine

Lots of good details can be found on their website: Cel-Sci.com.  But the best recap is their Corporate Presentation.  Link here: CORPORATE PRESENTATION


Probably the most accurate and concise article written was here on SeekingAlpha


Zacks provided a nice recap recently as well.  Link here: ZACKS

Trial "should have" ended in December 2018, why the "delay"?

Delays are never good, right? Here is the thing...  The trial ends when the 298th event (death) happens.  But people aren't dying as fast as statistics would suggest for survival of Head and Neck cancer patients.  Why?  We believe its Multikine.  In the new Corporate Presentation released on 7/2/19, it stated   "We are currently waiting for 298 events (deaths) in the two main groups to prove an overall survival benefit."  


The IDMC recently, 3/29/19, reviewed the UNBLINDED data for efficacy, safety and FUTILITY.  Their recommendation: Continue the trail until the last event!  Details Here


Need more proof and you're a Stats Junkie?  Then head on over to the Google Sheets created by our "National Treasure" FOSCO and team from the iHub message boards.  These sheets estimate that we are now past 10% of Standard Care.  These sheets take into account all different survival stats for Head and Neck cancer patients at 3 and 5 yrs.   Feel free to poke around...don't worry the sheets are protected and you cant mess anything up!


GOOGLE SHEETS

Straight from the CEO himself. BTW he has over 1M shares

On 6/18, this Conference video came out:

Video


On 5/16, a new interview came out:

Video


On 5/8, Geert issued a Press Release:

Shareholder Letter


Geert did an interview 5/2/19

ThinkEquity Interview 


4/11/19 Interview with Geert. Link below:

Interview

 

Recent Articles on CEL-SCI

 With much effort, our team has published the following articles on SeekingAlpha:


THESE ARE MUST READS! 

THE IDMC NEWS WAS HUGE

On 3/29/19, Cel-Sci released a PR stating that the IDMC has done their recent interim review and they made the following recommendation:


"continue the trial until the appropriate number of events have occurred."


PRESS RELEASE HERE


More info on the IDMC on our IDMC page


This is a big fucking deal!  At this point in the 8 year study, they have about 95% of all the data.  They would know if the study was futile or not.  If it was futile, they would have shut it down.


In the last 2 weeks the IDMC has shut down 3 trials for FUTILITY.  CVM just had the IDMC review their Phase III study for futility and recommended the trial should continue.  The 3 PRs link below are from the 3 recent trials that were just shut down:


 PRESS RELEASE HERE 

 

PRESS RELEASE HERE


PRESS RELEASE HERE


More about IDMC

Did You Visit The Hot "Alerts" Page?

Visit the Alerts page for the most recent news alerts!

Go To Hot Alerts

SHORTS ARE SPREADING RUMORS!

image8

Reverse Splits? Huh? That's Rich!!!!

REVERSE SPLITS is the latest SHORT tactic!  Yes, we have had 3 Reverse Splits. But that was then due to low share price.  Did you know a Reverse Split REQUIRES Shareholder approval? Its true. This approval request is done via a Proxy. Here is the latest Proxy: 

PROXY


****DID YOU SEE ANY REQUEST FOR AN APPROVAL OF A REVERSE SPLIT!?***


Furthermore, why would we do a Reverse Split now that we are at $5.00?  Are we at threat to be delisted?  No!  Here is why companies do Reverse Splits: 

REVERSE SPLIT INFO

Cash Cash and More Cash!

 This is always an issue with Biotechs.  Constant financing.  Dilution.  Wash, Rinse, Repeat.


The last 10Q as of 3/31/19 stated they have over $13M of cash.  No offering until early 2020!


Visit  Cash Page  for  current  details

The Stock Price Will Never Amount To Anything! Really?

Really?  We currently have a $295M (as of 7/2/19) Market Cap and a share price over $8.00.  Do some due diligence.  Upon a successful read out of the Phase III data, we are talking Billions and Billions!  I wont give you share price expectations, but what I will give you is recent buyouts of other bios:



Do the math!  We are at $295M with about 33M shares outstanding....How does one get to a $5B-$10B. Market Cap...?  The multiples are insane, but its possible!

Shorts Will Lie, Lie and Lie

Bashers Bash.  See why here: https://messageboardfools.com/bashers.htm 


They will say anything to make your give up your shares.  Stay long!